The state of congenital heart disease

Paul Kruszka1, Andrea Beaton2,3

  • 1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

Insights

This special issue updates readers on congenital heart disease (CHD), covering its epidemiology, genetics, and global impact. Significant research is still needed to understand the complexity of CHD.

Area of Science:

  • Medical Genetics
  • Pediatrics
  • Public Health

Background:

  • Congenital heart disease (CHD) remains a significant global health challenge.
  • Understanding the multifaceted nature of CHD is crucial for improving patient outcomes.
  • Existing knowledge gaps hinder comprehensive management and prevention strategies.

Purpose of the Study:

  • To provide a comprehensive overview of the current state of congenital heart disease research.
  • To highlight advances in understanding the epidemiology and genetic basis of CHD.
  • To discuss ethical considerations and the global impact of CHD.

Main Methods:

  • This special issue synthesizes current research and expert insights.
  • It reviews epidemiological data, genetic findings, and global health perspectives.
  • Ethical considerations are explored through expert discourse.

Main Results:

  • The epidemiology of CHD reveals varying global prevalence and risk factors.
  • Genetic and genomic research is uncovering complex etiological pathways.
  • Ethical dilemmas and the worldwide burden of CHD are significant concerns.

Conclusions:

  • Congenital heart disease (CHD) is a complex condition requiring continued intensive research.
  • Integrated approaches combining genetic, clinical, and public health strategies are essential.
  • Further investigation into the genetic and genomic underpinnings of CHD is paramount.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
614
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
313
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
365
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
348
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.8K